Global Epilepsy Drugs Market 2016-2020

SKU ID : TNV- 10279487

Publishing Date : 05-Jul-2016

No. of pages : 87


  • About the Epilepsy Drugs Market

    Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.
    Etiology varies according to the age of a person. Some individuals genetically inherit the disease while the cause of the disease in others is unknown. Head injuries, tumors, autism spectrum disorder, or stroke can also cause the disorder.

    Technavio’s analysts forecast the global epilepsy drugs market to grow at a CAGR of 4.45% during the period 2016-2020.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global epilepsy drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent epilepsy and related seizures. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of marketed drugs during the forecast period.

    The market is divided into the following segments based on geography:
    • Americas
    • APAC
    • EMEA

    Technavio's report, Global Epilepsy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    • Eisai
    • GSK
    • Pfizer
    • UCB

    Other prominent vendors
    • AbbVie
    • Acorda Therapeutics
    • Alexza Pharmaceuticals
    • Aprecia Pharmaceuticals
    • Aurobindo Pharma
    • Biscayne Pharmaceuticals
    • CURx Pharmaceuticals
    • Dainippon Sumitomo Pharma
    • D-Pharm
    • F. Hoffmann-La Roche
    • Grupo Ferrer Internacional
    • GW Pharmaceuticals
    • Insero Health
    • INSYS Therapeutics
    • Janssen Pharmaceuticals
    • Ligand Pharmaceuticals
    • H. Lundbeck
    • MarcoPolo Pharmaceuticals
    • Marinus Pharmaceuticals
    • Meda
    • Neurelis
    • Nobelpharma
    • Novartis
    • Orphelia Pharma
    • SAGE Therapeutics
    • SciFlour
    • Sedor Pharmaceuticals
    • Shire
    • SK Biopharmaceuticals
    • Sun Pharmaceutical
    • Sunovion Pharmaceuticals (US)
    • Supernus Pharmaceuticals
    • Takeda
    • Turing Pharmaceuticals
    • Upsher-Smith
    • Valeant Pharmaceutical
    • Zogenix

    Market driver
    • Tentative approval of late-stage pipeline molecules
    • For a full, detailed list, view our report

    Market challenge
    • Social stigma associated with epilepsy
    • For a full, detailed list, view our report

    Market trend
    • Reformulation of marketed drugs
    • For a full, detailed list, view our report

    Key questions answered in this report
    • What will the market size be in 2020 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?

    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

    Frequently Asked Questions

    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports